DYNAGLIPT-M 500/20 TAB
Rs 131.89 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
DYNAGLIPT-M 500/20 TAB
Dynaglipt-M Tablet is a combination antidiabetic medication containing Metformin and Teneligliptin, prescribed to manage type II diabetes mellitus. Metformin enhances the body’s sensitivity to insulin and decreases hepatic glucose production, while Teneligliptin, a DPP-4 inhibitor, increases insulin secretion and lowers blood glucose levels. This dual-action helps in better glycemic control. Patients are advised to take this medication orally, preferably after meals, with water, and avoid crushing or chewing it. Common side effects include hypoglycemia, gastrointestinal discomfort, headache, and altered taste. Patients with severe kidney, liver, or heart conditions should use this medication cautiously, and it is not recommended for those with type I diabetes or severe infections. Pregnant or breastfeeding women should consult their healthcare provider before use. Regular monitoring of blood sugar levels and kidney function is essential during treatment.
Product Highlights and Usage:
Combination Therapy: Contains Metformin and Teneligliptin, used to manage type II diabetes mellitus. Mechanism of Action: Metformin improves insulin sensitivity and decreases glucose production; Teneligliptin enhances insulin secretion by inhibiting the DPP-4 enzyme. Usage: Take orally, preferably after meals, as advised by a physician. Common Side Effects: Hypoglycemia, nausea, vomiting, diarrhea, constipation, and headache. Precautions: Not suitable for patients with severe kidney, liver, or heart problems; consult a doctor if pregnant or breastfeeding.
How it works:
DYNAGLIPT M TABLET is an antidiabetic medicine that contains two medications: metformin and teneligliptin. Metformin enhances the body's sensitivity to insulin, a hormone involved in glucose metabolism, allowing body cells to utilize more circulating blood glucose. Additionally, it inhibits glucose production by the liver and reduces its absorption in the body. Teneligliptin regulates blood sugar levels by inhibiting the enzyme dipeptidyl peptidase (DPP)-4, which decreases insulin secretion in the body. Together, DYNAGLIPT M TABLET manages blood sugar levels and improves glycemic control in patients with type II diabetes.
Directions for use:
Take DYNAGLIPT M TABLET preferably after meals or as advised by your physician. Swallow the medicine with a glass of water without crushing or chewing it. Your doctor will determine the appropriate dose and duration of therapy based on your age, body weight, and medical condition. Do not stop taking DYNAGLIPT M TABLET unless advised by your doctor.
Warning & Precaution:
PREGNANCY DYNAGLIPT M TABLET should be used in pregnant women only if considered necessary by the physician. Your doctor will prescribe DYNAGLIPT M TABLET only if the therapeutic benefits outweigh the risk to the fetus. Therefore, inform your doctor before taking it. BREASTFEEDING DYNAGLIPT M TABLET is not recommended for use in breastfeeding women. However, consult your doctor before taking it. DRIVING AND USING MACHINES Do not drive or operate any machines if you feel dizzy after taking DYNAGLIPT M TABLET. ALCOHOL Avoid consumption of alcohol while taking DYNAGLIPT M TABLET as it may increase the risk of unwanted side effects. KIDNEY DYNAGLIPT M TABLET is not recommended for use in patients with severely reduced kidney functions. Therefore, consult your doctor before taking it. LIVER DYNAGLIPT M TABLET is not recommended for use in patients with severe liver problems. It should be used with caution in patients with gall stones. Therefore, consult your doctor before taking it. ALLERGY Do not take DYNAGLIPT M TABLET if you are allergic to Metformin or Teneligliptin. LUNGS DYNAGLIPT M TABLET is not recommended for use in patients with severe infections of the lungs or respiratory tract. Therefore, consult your doctor before taking it. HEART DISEASE DYNAGLIPT M TABLET is not recommended for use in patients with severe heart problems (such as acute heart failure, recent heart attack, arrhythmia, prolonged QT interval). Therefore, consult your doctor before taking it. USE IN PEDIATRICS The safety and effectiveness of DYNAGLIPT M TABLET have not been established in infants, children, and adolescents (aged below 18 years). Therefore, consult your doctor before taking it. USE IN GERIATRICS The safety and effectiveness of DYNAGLIPT M TABLET have not been established in elderly patients (aged 65 years or above). Therefore, consult your doctor before taking it.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$